Glabellar Neuromodulator 2205-79

This study will assessed the aesthetic improvement and onset of a new liquid formulation botulinum toxinA when used to treat the glabellar lines. Dr. Cox is served as principal investigator. This study began in May 2022 and ended in January 2024.